Vasculitis following influenza vaccination: a review of the literature

T Watanabe - Current Rheumatology Reviews, 2017 - ingentaconnect.com
Background: Influenza vaccine is safe and effective for the general population as well as for
patients with autoimmune diseases. However, although rare, vasculitis has been reported as …

[PDF][PDF] Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs

PL Meroni, D Zavaglia, C Girmenia - Clin Exp Rheumatol, 2018 - clinexprheumatol.org
Patients with rheumatoid arthritis are at greater risk of infectious morbidity and mortality due
to disease-related abnormalities and use of immunosuppressive medications. Vaccinations …

[HTML][HTML] Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists

V Germano, MS Cattaruzza, J Osborn… - Journal of translational …, 2014 - Springer
Background Infections which complicate rheumatic diseases such as Rheumatoid Arthritis
(RA) and Spondyloarthropathy (SpA)(Psoriatic Arthritis [PA] and Ankylosing Spondylitis …

2018 APLAR axial spondyloarthritis treatment recommendations

LS Tam, JCC Wei, A Aggarwal, HJ Baek… - … journal of rheumatic …, 2019 - Wiley Online Library
Introduction Despite the availability of axial spondyloarthritis (SpA) recommendations
proposed by various rheumatology societies, we considered that a region‐specific guideline …

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis

AC Ribeiro, IM Laurindo, LK Guedes… - Arthritis care & …, 2013 - Wiley Online Library
Objective To evaluate the influence of abatacept (ABA) and associated contributing factors
on pandemic 2009 influenza A/H1N1 vaccine immunogenicity in rheumatoid arthritis (RA) …

[HTML][HTML] Current treatment for myositis

S Barsotti, IE Lundberg - Current Treatment Options in Rheumatology, 2018 - Springer
Purpose of review The purpose of this review was to give an update on treatment modalities
for patients with idiopathic inflammatory myopathies, or shortly myositis, excluding the …

A review on SLE and malignancy

MY Choi, K Flood, S Bernatsky… - Best practice & research …, 2017 - Elsevier
Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease
characterized by autoantibody production, complement activation, and immune complex …

Innate immunity and interferons in the pathogenesis of Sjögren's syndrome

ILA Bodewes, A Björk, MA Versnel… - …, 2021 - academic.oup.com
Primary SS (pSS) is a rheumatic disease characterized by an immune-mediated
exocrinopathy, resulting in severe dryness of eyes and mouth. Systemic symptoms include …

Predicting post-vaccination autoimmunity: who might be at risk?

A Soriano, G Nesher, Y Shoenfeld - Pharmacological Research, 2015 - Elsevier
Vaccinations have been used as an essential tool in the fight against infectious diseases,
and succeeded in improving public health. However, adverse effects, including autoimmune …

Giant cell arteritis

GS Hoffman - Annals of Internal Medicine, 2016 - acpjournals.org
This issue provides a clinical overview of giant cell arteritis, focusing on diagnosis,
treatment, and practice improvement. The content of In the Clinic is drawn from the clinical …